darolutamide Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (2)

Phase 1 (1)
Phase 3 (1)

Interventional (2)

Celgene (1)
Exelixis (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadluteinizing hormone

I am/have/hadmetastatic hormone refractory prostate cancer

I am/have/hadbone disease

I am/have/hadprostate adenocarcinoma

I am/have/hadcastration-resistant prostate cancer

I am/have/hadsoft tissue disease

I am/have/hadprostate cancer

I am/have/hadcancer

I am/have/hadserum testosterone

I am/have/hadhormonal therapy

I am/have/hadadenocarcinoma

I am/have/hadadenocarcinoma of prostate

I am/have/hadprostate specific antigen

I am/have/hadorchiectomy

I am/have/hadandrogen suppression

I am/have/hadlymphadenopathy

I am/have/hadprogressive disease

I am/have/hadbilateral orchidectomy

I am/have/hadmedical castration

I am/have/hadmetastatic prostate cancer

added new label for I am/have/had

more

I am looking for

I am looking forluteinizing hormone

I am looking forandrogens

I am looking forantiandrogen therapy

I am looking forcabozantinib

I am looking forabiraterone

I am looking forgonadotropin releasing hormone

I am looking forenzalutamide

I am looking forapalutamide

I am looking forhormone therapy

I am looking fortestosterone

I am looking fordarolutamide

I am looking forgonadorelin

I am looking foratezolizumab

I am looking foradrenal

I am looking forprednisone

I am looking forendocrine therapy

I am looking forgonadotropin

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Males
Recruiting

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

This is a Phase 3, multi-center, randomized, open-label, controlled study designed to evaluate the safety and efficacy of cabozantinib given in combination with atezolizumab versus a second novel hormonal therapy (NHT) in men with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with one, and only one, NHT …

metastatic hormone refractory prostate cancer

bone disease

prostate adenocarcinoma

cabozantinib

castration-resistant prostate cancer

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Family Medicine
Recruiting

Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

luteinizing hormone

metastatic hormone refractory prostate cancer

androgens

antiandrogen therapy

castration-resistant prostate cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.